NTRC (recognized by DSIR, Govt. of India) – is an advanced center established with a view to be at par with international standards in both pre-clinical and clinical research. The infrastructure of the facility is of world class with a built in area of 16,000 Sq.Ft. which includes – Clinical Research Division, Conference Room, four Biosafety level II clean rooms with laminar air flow type II- A in each room to carry out Stem Cell, Molecular biology and Genetic studies. A central Laboratory exists with state of art instruments such as Real- Time PCR, Ultra High Performance Liquid Chromatography (UHPLC), Flow Cytometer, Inverted Fluorescence Microscope, Nanodrop and Microbiology incubator and Laminar hood. As well equipped with necessary equipment’s including cooling centrifuges, refrigerators and freezers (-20 & -80 deg. C), Gel-documentation system and an IR Camera. Outcome of various research activities carried out in this centre were published in both national and international reputed journals.
A two-storeyed Animal facility was established in 1999 and utilized for experimental research in accordance with the CPCSEA guidelines of the Government of India. It fully air –conditioned and houses lab animals such as rats, mice, rabbits and guinea pigs. It facilitates the following activities – UG and PG pharmacy animal practical experiments; in-house medical and paramedical research; inter-institutional research and industrial research. Animal health and well-being is monitored daily by a veterinarian; and animals were well maintained and fed ad libitum by animal care-takers (24 h x 7 d)
|1||Dr. Srinivasa Rao||Associate Professor|
|2||Dr. K. Babu Rao||Veterinarian|
|3||Ms. Priyanka||Research Assistance|
|4||Ms. A.Mohana Rupa||Research Assistance|
|5||Mr. K. Bhargav Ram||Computer Assistant|
|6||Mr. V. Eswaraiah||Lab Assistant|
|7||Mr. Rahamathulla Kaja||Animal Care Staff|
|8||Mrs. Mabajan B||Animal Care Staff|
|9||Mrs. S.K Bashera||Sweeper – Animal House|
|10||Mrs. Ramanamma||Sweeper – Research Lab and Clinical Division|
|Sl.no||Name of the Instrument||Model /Make|
|1||Flow Cytometer||BD FACSCanto ll|
|2||HPLC||Thermo Scientific Ultimate 3000|
|3||Atomic Absorption Spectroscopy||Shimadzu|
|4||Inverted fluorescence microscope||Olympus U- LH100HG|
|5||RT-PCR||Bio-Rad; CFX 96|
|6||Deep Freezers (-20 deg. C & -80 deg. C )||LG & Terumo penpol DF80U 300L;|
|7||Laminar airflow type II A and CO2 Incubators||Thermo Fisher|
|8||Gel Documentation Unit||G-Box|
|10||Nanodrop||Thermo Fisher 2000|
|11||Microbiology hood and incubator||Hitech; Technico|
|12||Hot air oven||Yarko|
|15||Flame Photometer||Systronics 129|
|17||Muffle Furnace||BTI Biotech|
|Sl. No||Titles||Dept||Principal Investigator|
|1||A Randomised Double Blind, Three – Arm, placebo Controlled, Parallel – design, Multi- center, Clinical endpoint Bioequivalence study to ketoconazole shampoo 2% (Test Product) compared with ketoconazole shampoo 2% (Reference Product) in adult subjects with tinea versicolor||Dermatology Study||Dr. Shabana Shaik|
|2||Developement, validation and scale-up of point of care, wearable tinnitus care device patch and automated Smartphone app for management of tinnitus||ENT||Dr V Krishna Chaitanya Professor ENT Narayana Medical College Nellore|
|1||An Academic Multicentre Open Label Single Arm Study to Record the Efficacy of Indomethacin among Confirmed COVID-19 patients with Mild and Moderate Symptoms||Pulmonology||Dr.Prasanna purna|
|2||An Academic Retrospective Study to Record the Efficacy of Paracetamol along With|
Other Drugs, Among Confirmed Covid-l9 Patients with Mild and Moderate Symptoms
|3||clinical evaluation for the prophylactic role of traditional Siddha formulation Vishasura Kudineer enlisted|
in Advisory of the Ministry of AYUSH for COVID-19
|Pulmonology||Dr. Prasanna purna|
|4||An Academic Study to Evaluate Laphre-A Vaginal Pessary for Treatment of|
|Obstetrics and Gynecology||Dr.Neha|
|5||An open-label, Balanced, Randomized, Multicentre, Multi-Dose, Two-Treatment, Parallel, Comparative|
phase ilt ClinicalTrialto Determine the safety and Efficacy of Biapenem 300mg lnjections with l-nem (lmipenem 500 mg+ Cilastin 500 mg)injection in lndian Human Adult, Patients with Various Complicated lnfections.
|General Medicine||Dr.Bheemasen soren|
|6||An academic study of the Investigation of Digital Biomarkers for Early Detection|
of Surgical Site Infections.
|General Surgery||Dr.Mahidhar reddy|
|7||A Prospective, Randomized, Active controlled, observer-blind clinical study safety Evaluating the and Hemostat efficacy of Absorbabre Hemostat powder in comparison with AristarM AH (Absorbabre Hemostat) in Mild or Moderate parenchymal or Soft Tissue Bleeding during General Surgery.||General Surgery||Dr.Mahidhar reddy|
|8||Randomized, Parallel Group, Phase III Study to Compare Safety and Efficacy of|
BFLUID with a Commercially Available Solution,IYUTRIFLEX PBRI as a Control product in
Patients undergoing Gastrectomy or Colectomy
|Surgical Gastro entomology||Dr. Thirunavukkarasu|
|9||A Prospective, Mulu-center, phase IV Study to|
Assess the Safety, Efficacy and Immunogenicity of
BIOSULIN@ 30:70 (Insulin Injection, Biphasic Isophane
100 IU/ml) in Treatment
of Patients Diagnosed with Type 2 Diabetes Mellitus
|10||Phase IV, Multi-Center, Open Lable, Clinical Trial to Assess the Safety and Efficacy of Remdesivir in Moderate to Severe SARS CoV2 Infection (COVID-19) in Indian patients.||Pulmonology||Dr. Prasanna purna || Co-PI : Dr. Ravi Teja|
|11||A Prospective, Open Label, Multicenter, Single Arm Phase Iv Study to Evaluate the Safety and Effectiveness of Avigan® (Favipiravir) Tablets 200 Mg as Add On to Standard Supportive Care in Adult Indian Patients with Mild to Moderate Covid-19 Disease- Project submitted and in evaluation process||Pulmonology||Dr. Chappadi Rajesh Reddy|| Co-PI : Dr. PrasannaPurna|
|12||Randomized, Parallel Group, Phase III Study to Compare Safety and Efficacy of BFLUID with a Commercially Available Solution, NUTRIFLEX PERI, as a Control Product in Patients Undergoing Gastrectomy or Colectomy||Surgical Gastro entomology||Dr. Thirunavukkarasu|
Dr. Ishima Badhwar, M.B.B. S, M. Tech, Clinical Consultant Elsevier, Head of Customer engagement division, Elsevier India and South Asia.
Total two hundred and forty-four registrants were from India (95%) and other countries (5%) which includes – Bahrain, Sweden, Japan and Malaysia. Indian registrants were from across the country with higher percentage from Andhra Pradesh (75%), followed by Tamil Nadu (11%), and Telangana (9%); rest of the 2% are from the following states – Maharashtra, Karnataka, New Delhi and Haryana.
Reference Link-Scientific Writing and Searching Medical Databases | Narayana Medical COllege
Dr. Venugopalan Cheriyath & Dr. Izhar A Khan, are Associate Professors from Dept. of Biological Sciences, Texas A&M University-Commerce, Texas, USA.
Total Registrants –494, From India – 96%, Rest of the world 4% – from the following countries – United States of America (USA), Saudi Arabia, Oman, Qatar, Bahrain, Ethiopia, Malaysia and Japan. Distribution of registrants from different states of India is as follows – Andhra Pradesh (30%), Tamil Nadu (17%), Karnataka (14%), Puducherry (7%), Telangana (5%), Kerala (5%), rest 22% are from – Maharashtra, Uttar Pradesh, Punjab, Jharkhand, Rajasthan, Madhya Pradesh, West Bengal, Uttrakhand, Himachal Pradesh, Gujarat, Haryana and Odisha.
Reference Link-International Webinar on PhD Thesis Writing | Narayana Medical College Nellore
I. Dr. Madhavi Dokur, Ph.D, Head of HSE, Shantha Biotechnics Pvt. Limited, (A Sanofi Company), Hyderabad, India.
II. Dr. Richa Arya, Ph.D, Assistant Professor, Cytogenetics Laboratory, Department of Zoology, Banaras Hindu University, Varanasi, India.
Registrants – 548, out of it 532 are from India (97.1%), rest are from the following countries – United States of America (USA), United Kingdom (UK), Germany, Japan and Saudi Arabia. Distribution of registrants from different states of India is as follows – Andhra Pradesh (81%), Tamil Nadu (14%), Karnataka (3%), rest 2% are from – Maharashtra, Telangana, Uttar Pradesh, Punjab, Jharkhand, Rajasthan and Kerala.
Reference Link-minutes of biosafety | Narayana Medical College
Dr. Narasimman Gurusamy, University of Tennessee Health Science Centre (UTHSC), Memphis, Tennessee (TN), USA.
Registrants – 539 out of it 529 are from India (98%), rest are from the following countries – United States of America (USA), Japan and Saudi Arabia. Distribution of registrants from different states of India is as follows – Andhra Pradesh (95%), Tamil Nadu (2%), Kerala (2%), rest are from – Maharashtra, Telangana, Uttar Pradesh, Karnataka and Uttarakhand.
Reference Link-therapeutic applications of human induced pluripotent stem cells
I. Dr. Noohu Abdullah Khan, Assistant Professor, Clinical Pharmacy, King Khalid University, Kingdom of Saudi Arabia.
II. Dr. Ayyub Ali Patel, Assistant Professor, Dept. of Biochemistry, College of Medicine, King Khalid University, Kingdom of Saudi Arabia.
Total Four Hundred and Thirty-two (432) registrants; Indian registrants – 98%, foreign nationals -2% from USA, Oman and Saudi Arabia. Indian registrants are from the following states – Andhra Pradesh (69%), Tamil Nadu (20%), Maharashtra (4%), Karnataka (2%) and rest 2% are from Telangana and Kerala.
Reference Link-international webinar on computerised assessment blended learning in medical education/
Seminar on “Micronutrient Deficiencies – Hidden Hunger”, by Dr. Malavika Vinod Kumar, Managing Trustee, Sundar Serendipity Foundation & The Micronutrient Research Foundation, Chennai, Tamil Nadu, India; on January 25, 2021
National Webinar on “Stress – Paradigm Shift”, by T.S.I. Sakthi Siva Kumar, Sr. Manager, Training & Development, TTK Healthcare Ltd. Chennai, Tamil Nadu, India; on May 8, 2021. (Stress-A-Paradigm-Shift-Webinar-Minutes.pdf (narayanamedicalcollege.com))
International Webinar on “Mass Spectrometry-based Proteomics & its Application in Medicine”, by Dr. Srinivasan Yuvaraj, M.Sc., Ph.D. Project Scientist, Institute of Genome Research, Tokushima University, Tokushima, Japan; on 5th July, 2021 ((Intl-Webinar-Proteomics-application-in-Medicine-July-5-2021.pdf (narayanamedicalcollege.com))
Institute Innovation Council activity (IIC) – Strategies to Promote Innovation, Invention & Entrepreneurship, by Dr. Sivakumar Vijayaraghavalu, Prof & Head, Narayana Translational Research and Incubation Center; 5th August, 2021. (INSTITUTIONS INNOVATION COUNCIL First Quarterly meeting (narayanamedicalcollege.com)
(General Management Program, Harvard Business School, USA) Founder and Chief Executive Officer, Crely Healthcare Private Limited, 7 Temasek Blvd, Singapore 038987; on August 19, 2021